nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—Triamcinolone—allergic rhinitis	0.238	0.424	CbGbCtD
Tafluprost—PTGS2—Betamethasone—allergic rhinitis	0.204	0.364	CbGbCtD
Tafluprost—PTGS2—Dexamethasone—allergic rhinitis	0.119	0.212	CbGbCtD
Tafluprost—PTGFR—Prostanoid ligand receptors—PTGDR2—allergic rhinitis	0.0373	0.296	CbGpPWpGaD
Tafluprost—Foreign body sensation in eyes—Olopatadine—allergic rhinitis	0.0287	0.105	CcSEcCtD
Tafluprost—PTGFR—Eicosanoid ligand-binding receptors—PTGDR2—allergic rhinitis	0.0248	0.197	CbGpPWpGaD
Tafluprost—Erythema of eyelid—Olopatadine—allergic rhinitis	0.0243	0.089	CcSEcCtD
Tafluprost—PTGFR—Eicosanoid ligand-binding receptors—CYSLTR1—allergic rhinitis	0.0194	0.154	CbGpPWpGaD
Tafluprost—Eye discharge—Olopatadine—allergic rhinitis	0.0189	0.069	CcSEcCtD
Tafluprost—Punctate keratitis—Olopatadine—allergic rhinitis	0.0176	0.0644	CcSEcCtD
Tafluprost—Ocular hyperaemia—Olopatadine—allergic rhinitis	0.00948	0.0347	CcSEcCtD
Tafluprost—Endophthalmitis—Olopatadine—allergic rhinitis	0.00934	0.0341	CcSEcCtD
Tafluprost—Eyelid oedema—Olopatadine—allergic rhinitis	0.00881	0.0322	CcSEcCtD
Tafluprost—Visual acuity reduced—Olopatadine—allergic rhinitis	0.00748	0.0273	CcSEcCtD
Tafluprost—PTGFR—respiratory system—allergic rhinitis	0.00557	0.188	CbGeAlD
Tafluprost—Eye irritation—Olopatadine—allergic rhinitis	0.00521	0.019	CcSEcCtD
Tafluprost—PTGFR—eye—allergic rhinitis	0.00509	0.172	CbGeAlD
Tafluprost—Lacrimation increased—Olopatadine—allergic rhinitis	0.00483	0.0176	CcSEcCtD
Tafluprost—PTGFR—bronchus—allergic rhinitis	0.00458	0.155	CbGeAlD
Tafluprost—Photophobia—Olopatadine—allergic rhinitis	0.00418	0.0153	CcSEcCtD
Tafluprost—PTGFR—trachea—allergic rhinitis	0.00411	0.139	CbGeAlD
Tafluprost—Dry eye—Olopatadine—allergic rhinitis	0.00411	0.015	CcSEcCtD
Tafluprost—Eye pain—Olopatadine—allergic rhinitis	0.00358	0.0131	CcSEcCtD
Tafluprost—Nasopharyngitis—Desloratadine—allergic rhinitis	0.00338	0.0123	CcSEcCtD
Tafluprost—Lacrimation increased—Flunisolide—allergic rhinitis	0.00336	0.0123	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Prednisolone—allergic rhinitis	0.00332	0.0122	CcSEcCtD
Tafluprost—Cataract—Flunisolide—allergic rhinitis	0.00326	0.0119	CcSEcCtD
Tafluprost—PTGFR—lung—allergic rhinitis	0.00296	0.1	CbGeAlD
Tafluprost—Nasopharyngitis—Olopatadine—allergic rhinitis	0.00289	0.0106	CcSEcCtD
Tafluprost—Urinary tract infection—Desloratadine—allergic rhinitis	0.00283	0.0103	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Dexamethasone—allergic rhinitis	0.00277	0.0101	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Betamethasone—allergic rhinitis	0.00277	0.0101	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.00258	0.0205	CbGpPWpGaD
Tafluprost—Endophthalmitis—Dexamethasone—allergic rhinitis	0.00256	0.00937	CcSEcCtD
Tafluprost—Endophthalmitis—Betamethasone—allergic rhinitis	0.00256	0.00937	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00254	0.0202	CbGpPWpGaD
Tafluprost—Eye pain—Cetirizine—allergic rhinitis	0.00254	0.00927	CcSEcCtD
Tafluprost—Urinary tract infection—Olopatadine—allergic rhinitis	0.00242	0.00884	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.00231	0.0183	CbGpPWpGaD
Tafluprost—Rhinitis—Olopatadine—allergic rhinitis	0.00224	0.00819	CcSEcCtD
Tafluprost—Vision blurred—Cyproheptadine—allergic rhinitis	0.0022	0.00806	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00218	0.0173	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.00216	0.0171	CbGpPWpGaD
Tafluprost—PTGS2—Fluocinonide—Flunisolide—allergic rhinitis	0.00216	0.213	CbGdCrCtD
Tafluprost—Eye disorder—Olopatadine—allergic rhinitis	0.00209	0.00763	CcSEcCtD
Tafluprost—Visual acuity reduced—Betamethasone—allergic rhinitis	0.00205	0.0075	CcSEcCtD
Tafluprost—Visual acuity reduced—Dexamethasone—allergic rhinitis	0.00205	0.0075	CcSEcCtD
Tafluprost—Nasopharyngitis—Cetirizine—allergic rhinitis	0.00205	0.00748	CcSEcCtD
Tafluprost—Nasopharyngitis—Flunisolide—allergic rhinitis	0.00201	0.00736	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.002	0.0159	CbGpPWpGaD
Tafluprost—Cough—Desloratadine—allergic rhinitis	0.00198	0.00725	CcSEcCtD
Tafluprost—Vision blurred—Olopatadine—allergic rhinitis	0.00183	0.0067	CcSEcCtD
Tafluprost—Nervous system disorder—Desloratadine—allergic rhinitis	0.00182	0.00665	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00181	0.0144	CbGpPWpGaD
Tafluprost—Vision blurred—Diphenhydramine—allergic rhinitis	0.00179	0.00656	CcSEcCtD
Tafluprost—Vision blurred—Dimenhydrinate—allergic rhinitis	0.00179	0.00656	CcSEcCtD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.00174	0.0138	CbGpPWpGaD
Tafluprost—Nasopharyngitis—Montelukast—allergic rhinitis	0.00172	0.00628	CcSEcCtD
Tafluprost—Urinary tract infection—Cetirizine—allergic rhinitis	0.00171	0.00627	CcSEcCtD
Tafluprost—Eye irritation—Prednisolone—allergic rhinitis	0.00171	0.00626	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00171	0.0136	CbGpPWpGaD
Tafluprost—Cough—Olopatadine—allergic rhinitis	0.0017	0.0062	CcSEcCtD
Tafluprost—Urinary tract infection—Flunisolide—allergic rhinitis	0.00169	0.00616	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00166	0.0132	CbGpPWpGaD
Tafluprost—Asthma—Montelukast—allergic rhinitis	0.00166	0.00607	CcSEcCtD
Tafluprost—Dyspnoea—Desloratadine—allergic rhinitis	0.00165	0.00605	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00165	0.0131	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00162	0.0129	CbGpPWpGaD
Tafluprost—Rhinitis—Cetirizine—allergic rhinitis	0.00159	0.00581	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.00158	0.0125	CbGpPWpGaD
Tafluprost—Rhinitis—Flunisolide—allergic rhinitis	0.00156	0.00571	CcSEcCtD
Tafluprost—Nervous system disorder—Olopatadine—allergic rhinitis	0.00156	0.00569	CcSEcCtD
Tafluprost—PTGS2—respiratory system—allergic rhinitis	0.00153	0.0518	CbGeAlD
Tafluprost—Cataract—Hydrocortisone—allergic rhinitis	0.0015	0.00549	CcSEcCtD
Tafluprost—Eye disorder—Cetirizine—allergic rhinitis	0.00148	0.00541	CcSEcCtD
Tafluprost—Dyspnoea—Olopatadine—allergic rhinitis	0.00141	0.00517	CcSEcCtD
Tafluprost—Cataract—Triamcinolone—allergic rhinitis	0.00141	0.00516	CcSEcCtD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.00141	0.0112	CbGpPWpGaD
Tafluprost—Rhinitis—Montelukast—allergic rhinitis	0.00133	0.00487	CcSEcCtD
Tafluprost—Dry eye—Hydrocortisone—allergic rhinitis	0.00132	0.00482	CcSEcCtD
Tafluprost—Pruritus—Desloratadine—allergic rhinitis	0.00131	0.0048	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.0013	0.0103	CbGpPWpGaD
Tafluprost—PTGS2—Fluticasone Propionate—Flunisolide—allergic rhinitis	0.0013	0.129	CbGdCrCtD
Tafluprost—Vision blurred—Cetirizine—allergic rhinitis	0.0013	0.00475	CcSEcCtD
Tafluprost—Cataract—Dexamethasone—allergic rhinitis	0.00128	0.00469	CcSEcCtD
Tafluprost—Cataract—Betamethasone—allergic rhinitis	0.00128	0.00469	CcSEcCtD
Tafluprost—PTGS2—epithelium—allergic rhinitis	0.00128	0.0433	CbGeAlD
Tafluprost—Cough—Loratadine—allergic rhinitis	0.00128	0.00467	CcSEcCtD
Tafluprost—Vision blurred—Flunisolide—allergic rhinitis	0.00128	0.00467	CcSEcCtD
Tafluprost—PTGS2—bronchus—allergic rhinitis	0.00126	0.0426	CbGeAlD
Tafluprost—PTGFR—GPCR ligand binding—CCL11—allergic rhinitis	0.00126	0.00999	CbGpPWpGaD
Tafluprost—PTGS2—skin of body—allergic rhinitis	0.00122	0.0412	CbGeAlD
Tafluprost—Cough—Cetirizine—allergic rhinitis	0.0012	0.0044	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.0012	0.00953	CbGpPWpGaD
Tafluprost—Headache—Cyproheptadine—allergic rhinitis	0.0012	0.00437	CcSEcCtD
Tafluprost—Cough—Flunisolide—allergic rhinitis	0.00118	0.00432	CcSEcCtD
Tafluprost—Nervous system disorder—Loratadine—allergic rhinitis	0.00117	0.00429	CcSEcCtD
Tafluprost—Headache—Desloratadine—allergic rhinitis	0.00116	0.00425	CcSEcCtD
Tafluprost—PTGS2—trachea—allergic rhinitis	0.00113	0.0383	CbGeAlD
Tafluprost—Dry eye—Dexamethasone—allergic rhinitis	0.00113	0.00412	CcSEcCtD
Tafluprost—Dry eye—Betamethasone—allergic rhinitis	0.00113	0.00412	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.00112	0.00892	CbGpPWpGaD
Tafluprost—Pruritus—Olopatadine—allergic rhinitis	0.00112	0.0041	CcSEcCtD
Tafluprost—Nervous system disorder—Cetirizine—allergic rhinitis	0.0011	0.00403	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Methylprednisolone—allergic rhinitis	0.00106	0.104	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Dexamethasone—allergic rhinitis	0.00104	0.103	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Betamethasone—allergic rhinitis	0.00104	0.103	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Triamcinolone—allergic rhinitis	0.00102	0.1	CbGdCrCtD
Tafluprost—Cough—Montelukast—allergic rhinitis	0.00101	0.00369	CcSEcCtD
Tafluprost—Dyspnoea—Cetirizine—allergic rhinitis	0.001	0.00367	CcSEcCtD
Tafluprost—Headache—Olopatadine—allergic rhinitis	0.000994	0.00363	CcSEcCtD
Tafluprost—Dyspnoea—Flunisolide—allergic rhinitis	0.000986	0.00361	CcSEcCtD
Tafluprost—Eye pain—Dexamethasone—allergic rhinitis	0.000981	0.00359	CcSEcCtD
Tafluprost—Eye pain—Betamethasone—allergic rhinitis	0.000981	0.00359	CcSEcCtD
Tafluprost—Headache—Diphenhydramine—allergic rhinitis	0.000973	0.00356	CcSEcCtD
Tafluprost—Headache—Dimenhydrinate—allergic rhinitis	0.000973	0.00356	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000938	0.00745	CbGpPWpGaD
Tafluprost—Nervous system disorder—Montelukast—allergic rhinitis	0.000925	0.00338	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—TAC1—allergic rhinitis	0.000914	0.00726	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000852	0.00677	CbGpPWpGaD
Tafluprost—Asthma—Triamcinolone—allergic rhinitis	0.000844	0.00308	CcSEcCtD
Tafluprost—PTGS2—lung—allergic rhinitis	0.000812	0.0275	CbGeAlD
Tafluprost—Pruritus—Cetirizine—allergic rhinitis	0.000796	0.00291	CcSEcCtD
Tafluprost—Pruritus—Flunisolide—allergic rhinitis	0.000783	0.00286	CcSEcCtD
Tafluprost—Headache—Loratadine—allergic rhinitis	0.000749	0.00274	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000736	0.00585	CbGpPWpGaD
Tafluprost—Headache—Cetirizine—allergic rhinitis	0.000705	0.00258	CcSEcCtD
Tafluprost—Headache—Flunisolide—allergic rhinitis	0.000693	0.00253	CcSEcCtD
Tafluprost—Rhinitis—Triamcinolone—allergic rhinitis	0.000677	0.00248	CcSEcCtD
Tafluprost—Rhinitis—Methylprednisolone—allergic rhinitis	0.000675	0.00247	CcSEcCtD
Tafluprost—Eye disorder—Hydrocortisone—allergic rhinitis	0.00067	0.00245	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000668	0.00531	CbGpPWpGaD
Tafluprost—Pruritus—Montelukast—allergic rhinitis	0.000668	0.00244	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CCL11—allergic rhinitis	0.000645	0.00513	CbGpPWpGaD
Tafluprost—PTGS2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	0.000637	0.063	CbGdCrCtD
Tafluprost—Eye disorder—Methylprednisolone—allergic rhinitis	0.00063	0.0023	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	0.000627	0.062	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Betamethasone—allergic rhinitis	0.000627	0.062	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	0.000612	0.0606	CbGdCrCtD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000604	0.0048	CbGpPWpGaD
Tafluprost—Vision blurred—Prednisolone—allergic rhinitis	0.000602	0.0022	CcSEcCtD
Tafluprost—Headache—Montelukast—allergic rhinitis	0.000591	0.00216	CcSEcCtD
Tafluprost—Eye disorder—Dexamethasone—allergic rhinitis	0.000573	0.00209	CcSEcCtD
Tafluprost—Eye disorder—Betamethasone—allergic rhinitis	0.000573	0.00209	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000568	0.00451	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL4—allergic rhinitis	0.000565	0.00449	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—TAC1—allergic rhinitis	0.000516	0.0041	CbGpPWpGaD
Tafluprost—Cough—Triamcinolone—allergic rhinitis	0.000513	0.00188	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—PTGDR2—allergic rhinitis	0.000503	0.004	CbGpPWpGaD
Tafluprost—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.0005	0.00183	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—IL5—allergic rhinitis	0.00048	0.00381	CbGpPWpGaD
Tafluprost—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000469	0.00172	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—TAC1—allergic rhinitis	0.000469	0.00373	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000449	0.00357	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL5—allergic rhinitis	0.000436	0.00346	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CD4—allergic rhinitis	0.000433	0.00344	CbGpPWpGaD
Tafluprost—Dyspnoea—Triamcinolone—allergic rhinitis	0.000428	0.00156	CcSEcCtD
Tafluprost—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000427	0.00156	CcSEcCtD
Tafluprost—Nervous system disorder—Betamethasone—allergic rhinitis	0.000427	0.00156	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000395	0.00314	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL11—allergic rhinitis	0.000381	0.00303	CbGpPWpGaD
Tafluprost—Pruritus—Hydrocortisone—allergic rhinitis	0.00036	0.00132	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.000359	0.00286	CbGpPWpGaD
Tafluprost—Pruritus—Triamcinolone—allergic rhinitis	0.000339	0.00124	CcSEcCtD
Tafluprost—Pruritus—Methylprednisolone—allergic rhinitis	0.000339	0.00124	CcSEcCtD
Tafluprost—Headache—Prednisolone—allergic rhinitis	0.000327	0.00119	CcSEcCtD
Tafluprost—Headache—Hydrocortisone—allergic rhinitis	0.000319	0.00117	CcSEcCtD
Tafluprost—Pruritus—Betamethasone—allergic rhinitis	0.000308	0.00113	CcSEcCtD
Tafluprost—Pruritus—Dexamethasone—allergic rhinitis	0.000308	0.00113	CcSEcCtD
Tafluprost—Headache—Triamcinolone—allergic rhinitis	0.000301	0.0011	CcSEcCtD
Tafluprost—Headache—Methylprednisolone—allergic rhinitis	0.0003	0.0011	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—TAC1—allergic rhinitis	0.000277	0.0022	CbGpPWpGaD
Tafluprost—Headache—Betamethasone—allergic rhinitis	0.000273	0.000997	CcSEcCtD
Tafluprost—Headache—Dexamethasone—allergic rhinitis	0.000273	0.000997	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—IL5—allergic rhinitis	0.000258	0.00205	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000237	0.00188	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000193	0.00154	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SMAD3—allergic rhinitis	0.000181	0.00144	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000161	0.00128	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NFKB1—allergic rhinitis	9.21e-05	0.000732	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SMAD3—allergic rhinitis	8.45e-05	0.000671	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—allergic rhinitis	7.68e-05	0.00061	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD4—allergic rhinitis	4.98e-05	0.000396	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—allergic rhinitis	3.58e-05	0.000284	CbGpPWpGaD
